BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03075696-completion@plaintrial.com
DTSTAMP:20261027T091159Z
DTSTART;VALUE=DATE:20291231
SUMMARY:A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent
  and in Combination With Obinutuzumab\, Administered After a Fixed\, Singl
 e Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refract
 ory B-cell Non-hodgkin's Lymphoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03075696
URL:https://plaintrial.com/trial/NCT03075696
END:VEVENT
END:VCALENDAR
